BioLife Solutions price target raised to $31 from $28 at TD Cowen
The Fly

BioLife Solutions price target raised to $31 from $28 at TD Cowen

TD Cowen raised the firm’s price target on BioLife Solutions (BLFS) to $31 from $28 and keeps a Buy rating on the shares. The firm said core revenues of $27M beat consensus driven by Cell Processing strength. Management feels the macro environment is largely normalized driving this segment with 80% of revenues coming from top-20 pharma.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App